Tecan Group AG
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TCHBF research report →
Companywww.tecan.com
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions.
- CEO
- Monica Manotas
- IPO
- 2013
- Employees
- 3,074
- HQ
- Männedorf, CH
Price Chart
Valuation
- Market Cap
- $2.24B
- P/E
- -16.61
- P/S
- 2.08
- P/B
- 1.60
- EV/EBITDA
- 26.88
- Div Yield
- 2.07%
Profitability
- Gross Margin
- 35.22%
- Op Margin
- 5.07%
- Net Margin
- -12.54%
- ROE
- -9.09%
- ROIC
- 3.13%
Growth & Income
- Revenue
- $882.90M · -5.50%
- Net Income
- $-110,706,047 · -263.61%
- EPS
- $-8.74 · -264.91%
- Op Income
- $42.19M
- FCF YoY
- -12.89%
Performance & Tape
- 52W High
- $211.90
- 52W Low
- $155.25
- 50D MA
- $164.96
- 200D MA
- $172.89
- Beta
- 1.01
- Avg Volume
- 5
Get TickerSpark's AI analysis on TCHBF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TCHBF Coverage
We haven't published any research on TCHBF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TCHBF Report →